Literature DB >> 7630162

Role of Na+/phosphate-cotransporter in myocardial contractile responses to alpha 1-agonist.

M O Onwochei1.   

Abstract

The interaction of cardiac sodium/phosphate (Na+/Pi)-cotransporter and the phosphoinositide pathway (PIP) in influencing myocardial contraction was investigated. Specifically, the study was performed to determine if myocardial positive inotropic response (+dP/dt) to phenylephrine (PE, an activator of PIP) can be potentiated by inorganic phosphate (Pi, the substrate of Na+/Pi-cotransporter). Contractile responses of the isolated perfused rat heart were studied in conditions of controlled extracellular calcium activity and constant preload. The data showed that phenylephrine-induced increase in +dP/dt was potentiated by Pi. Prazosin inhibited this increase in +dP/dt, indicating alpha 1-adrenergic involvement. This Pi-potentiated increase in +dP/dt was also inhibited by phosphonoformate (PFA); however, only partial inhibition was obtained with concentrations of PFA that selectively inhibited Na+/Pi-cotransporter. Isoproterenol-induced increase in +dP/dt was not potentiated by Pi, showing that potentiation of +dP/dt is not a common effect of Pi. The data support an important interaction between PIP and Na+/Pi-cotransporter in regulating myocardial contraction.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7630162     DOI: 10.1097/00005344-199505000-00021

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  2 in total

1.  Blood pressure is regulated by an alpha1D-adrenergic receptor/dystrophin signalosome.

Authors:  John S Lyssand; Mia C DeFino; Xiao-bo Tang; Angie L Hertz; David B Feller; Jennifer L Wacker; Marvin E Adams; Chris Hague
Journal:  J Biol Chem       Date:  2008-05-09       Impact factor: 5.157

2.  Inorganic phosphate accelerates cardiac myofilament relaxation in response to lengthening.

Authors:  Jane I Wakefield; Stephen P Bell; Bradley M Palmer
Journal:  Front Physiol       Date:  2022-09-12       Impact factor: 4.755

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.